Aytu BioScience, Inc. Skyrocketed
Aytu BioScience, Inc. (AYTU:NASDAQ) soared at $2.67, representing a gain of 39.1%. On Thu, Sep 28, 2023, AYTU:NASDAQ hit a New 2-Week High of $2.67. The stock got featured on our News Catalysts scanner on Thu, Sep 28, 2023 at 04:37 AM in the 'EARNINGS' category. From Thu, Sep 14, 2023, the stock recorded 60.00% Up Days and 36.36% Green Days
The stock spiked on Thu, Apr 27, 2023 at $2.84 with a volume of 1M+.
About Aytu BioScience, Inc. (AYTU:NASDAQ)
Aytu BioScience Inc is a specialty pharmaceutical company commercializing novel products addressing patient needs. The company markets a portfolio of prescription products addressing large therapeutic markets. The primary care portfolio includes Natesto, the only FDA-approved nasal formulation of testosterone, ZolpiMist, the only FDA-approved oral spray prescription sleep aid, and Tuzistra XR, the only FDA-approved 12-hour codeine-based antitussive syrup. The pediatric portfolio includes AcipHex Sprinkle, Cefaclor, Karbinal ER, and Poly-Vi-Flor and Tri-Vi-Flor.
Top 10 Gainers:
- Bionomics Limited (BNOX:NASDAQ), 243.84%
- Digital Transformation Opportunities Corp. (DTOC:NASDAQ), 89.56%
- Chico's FAS, Inc. (CHS:NYSE), 63.12%
- Axcella Health Inc. (AXLA:NASDAQ), 52.97%
- Baudax Bio, Inc. (BXRX:NASDAQ), 50.67%
- Aytu BioScience, Inc. (AYTU:NASDAQ), 39.06%
- Sarcos Technology and Robotics Corporation (STRC:NASDAQ), 37.31%
- Femasys Inc. (FEMY:NASDAQ), 36.94%
- Vaccinex, Inc. (VCNX:NASDAQ), 34.82%
- Infinity Pharmaceuticals, Inc. (INFI:NASDAQ), 34.4%